Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

NCT02858908 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Myotonic Dystrophy 1

Interventions

DRUG: Tideglusib

Sponsor

AMO Pharma Limited